Follow this preprint
HLA-A*02:01 allele is associated with decreased risk and a longer survival in pancreatic cancer: Results from an exhaustive analysis of the HLA variation in PDAC
View ORCID ProfileAlberto Langtry, View ORCID ProfileRaul Rabadan, View ORCID ProfileLola Alonso, Casper van Eijck, View ORCID ProfileTeresa Macarulla, View ORCID ProfileRita T Lawlor, View ORCID ProfileAlfredo Carrato, Rafael Alvarez-Gallego, View ORCID ProfileMar Iglesias, View ORCID ProfileXavier Molero, View ORCID ProfileJ Matthias Löhr, Christopher W Michalski, José Perea, Michael O’Rorke, Víctor M Barberà, View ORCID ProfileAdonina Tardón, Antoni Farré, Luís Muñoz-Bellvís, View ORCID ProfileTatjana Crnogorac-Jurcevic, View ORCID ProfileEnrique Domínguez-Muñoz, View ORCID ProfileThomas Gress, View ORCID ProfileWilliam Greenhalf, View ORCID ProfileLinda Sharp, View ORCID ProfileSergio Sabroso-Lasa, Ioan Filip, View ORCID ProfileGaby Strijk, View ORCID ProfileFlorian Castet, View ORCID ProfileJoaquim Balsells, View ORCID ProfileEithne Costello, View ORCID ProfileJörg Kleeff, Bo Kong, Josefina Mora, Damian O’Driscoll, View ORCID ProfileAldo Scarpa, Weimin Ye, View ORCID ProfileFrancisco X. Real, View ORCID ProfileNúria Malats, View ORCID ProfileEvangelina López de Maturana PanGenEU Investigators
doi: https://doi.org/10.1101/2024.08.29.24312704
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
Alberto Langtry
1Genetic and Molecular Epidemiology Group, Spanish National Cancer Research Center (CNIO), and CIBERONC, Madrid, Spain
Raul Rabadan
2Department of Systems Biology, Columbia University, New York, NY, USA
Lola Alonso
1Genetic and Molecular Epidemiology Group, Spanish National Cancer Research Center (CNIO), and CIBERONC, Madrid, Spain
Casper van Eijck
1Genetic and Molecular Epidemiology Group, Spanish National Cancer Research Center (CNIO), and CIBERONC, Madrid, Spain
3Department of Surgery, Erasmus Medical Center, Rotterdam, The Netherlands
Teresa Macarulla
4Vall d’Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d’Hebron, Barcelona, Barcelona, Spain
Rita T Lawlor
5ARC-Net Center for Applied Research on Cancer, Department of Diagnostics and Public Health and Department of Engineering for Innovation Medicine, University of Verona, Verona, Italy
Alfredo Carrato
6Department of Oncology, Ramón y Cajal University Hospital, IRYCIS, Alcala University, Madrid, and CIBERONC, Spain
Rafael Alvarez-Gallego
7HM CIOCC Madrid (Centro Integral Oncológico Clara Campal). Hospital Universitario HM Sanchinarro. Instituto de Investigación Sanitaria HM Hospitales. Facultad HM de Ciencias de la Salud de la Universidad Camilo José Cela.
Mar Iglesias
8Hospital del Mar—Parc de Salut Mar, Barcelona, and CIBERONC, Spain
Xavier Molero
9Hospitals Universitaris Arnau de Vilanova i Santa Maria, IRBLleida, UdL, 25198, Lleida; and CIBEREHD, Madrid, Spain
J Matthias Löhr
10Gastrocentrum, Karolinska Institutet and University Hospital, Stockholm, Sweden
Christopher W Michalski
11Department of Surgery, Technical University of Munich, Munich; and Department of General, Visceral and Transplantation Surgery, Medical Faculty Heidelberg, University Heidelberg, Germany
José Perea
12Department of Surgery, Hospital 12 de Octubre, Madrid; and Institute of Biomedical Research of Salamanca, Salamanca, Spain
Michael O’Rorke
13Center for Public Health, Belfast, Queen’s University Belfast, UK; and College of Public Health, The University of Iowa, Iowa City, IA, US
Víctor M Barberà
14Molecular Genetics Laboratory, General University Hospital of Elche, Spain
Adonina Tardón
15Department of Medicine, Instituto Universitario de Oncología del Principado de Asturias (IUOPA), Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Oviedo, and CIBERESP, Spain
Antoni Farré
16Department of Gastroenterology and Clinical Biochemistry, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
Luís Muñoz-Bellvís
17Department of Surgery, Hospital Universitario de Salamanca – IBSAL. Universidad de Salamanca and CIBERONC, Spain
Tatjana Crnogorac-Jurcevic
18Barts Cancer Institute, Center for Cancer Biomarkers and Biotherapeutics, Queen Mary University of London, London, UK
Enrique Domínguez-Muñoz
19Department of Gastroenterology, University Clinical Hospital of Santiago de Compostela, Spain
Thomas Gress
20Department of Gastroenterology, University Hospital of Giessen and Marburg, Marburg, Germany
William Greenhalf
21Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, UK
Linda Sharp
22National Cancer Registry Ireland and HRB Clinical Research Facility, University College Cork, Cork, Ireland; and Newcastle University, Institute of Health & Society, Newcastle, UK
Sergio Sabroso-Lasa
1Genetic and Molecular Epidemiology Group, Spanish National Cancer Research Center (CNIO), and CIBERONC, Madrid, Spain
Ioan Filip
2Department of Systems Biology, Columbia University, New York, NY, USA
Gaby Strijk
3Department of Surgery, Erasmus Medical Center, Rotterdam, The Netherlands
Florian Castet
4Vall d’Hebron Institute of Oncology (VHIO), Hospital Universitari Vall d’Hebron, Barcelona, Barcelona, Spain
Joaquim Balsells
9Hospitals Universitaris Arnau de Vilanova i Santa Maria, IRBLleida, UdL, 25198, Lleida; and CIBEREHD, Madrid, Spain
Eithne Costello
21Department of Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, UK
Jörg Kleeff
23Department of Surgery, Technical University of Munich, Munich; and Department of Visceral, Vascular and Endocrine Surgery, Martin-Luther-University Wittenberg-Halle (Saale), Germany
Bo Kong
24Department of Surgery, Technical University of Munich, Munich
Josefina Mora
16Department of Gastroenterology and Clinical Biochemistry, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
Damian O’Driscoll
25National Cancer Registry Ireland and HRB Clinical Research Facility, University College Cork, Cork, Ireland
Aldo Scarpa
5ARC-Net Center for Applied Research on Cancer, Department of Diagnostics and Public Health and Department of Engineering for Innovation Medicine, University of Verona, Verona, Italy
Weimin Ye
26Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
Francisco X. Real
27Epithelial Carcinogenesis Group, Spanish National Cancer Research Center (CNIO) and CIBERONC, Madrid; and Pompeu Fabra University, Barcelona, Spain
Núria Malats
1Genetic and Molecular Epidemiology Group, Spanish National Cancer Research Center (CNIO), and CIBERONC, Madrid, Spain
Evangelina López de Maturana
1Genetic and Molecular Epidemiology Group, Spanish National Cancer Research Center (CNIO), and CIBERONC, Madrid, Spain
28In Annex 1
Data Availability
All data produced in the present study are available upon reasonable request to the authors
Posted November 14, 2024.
HLA-A*02:01 allele is associated with decreased risk and a longer survival in pancreatic cancer: Results from an exhaustive analysis of the HLA variation in PDAC
Alberto Langtry, Raul Rabadan, Lola Alonso, Casper van Eijck, Teresa Macarulla, Rita T Lawlor, Alfredo Carrato, Rafael Alvarez-Gallego, Mar Iglesias, Xavier Molero, J Matthias Löhr, Christopher W Michalski, José Perea, Michael O’Rorke, Víctor M Barberà, Adonina Tardón, Antoni Farré, Luís Muñoz-Bellvís, Tatjana Crnogorac-Jurcevic, Enrique Domínguez-Muñoz, Thomas Gress, William Greenhalf, Linda Sharp, Sergio Sabroso-Lasa, Ioan Filip, Gaby Strijk, Florian Castet, Joaquim Balsells, Eithne Costello, Jörg Kleeff, Bo Kong, Josefina Mora, Damian O’Driscoll, Aldo Scarpa, Weimin Ye, Francisco X. Real, Núria Malats, Evangelina López de Maturana
medRxiv 2024.08.29.24312704; doi: https://doi.org/10.1101/2024.08.29.24312704
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
0
Author Videos
Subject Areas
- Addiction Medicine (423)
- Allergy and Immunology (746)
- Anesthesia (219)
- Cardiovascular Medicine (3240)
- Dermatology (271)
- Emergency Medicine (476)
- Epidemiology (13259)
- Forensic Medicine (19)
- Gastroenterology (892)
- Genetic and Genomic Medicine (5072)
- Geriatric Medicine (471)
- Health Economics (774)
- Health Informatics (3199)
- Health Policy (1130)
- Hematology (423)
- HIV/AIDS (1005)
- Medical Education (468)
- Medical Ethics (126)
- Nephrology (515)
- Neurology (4829)
- Nursing (255)
- Nutrition (717)
- Oncology (2489)
- Ophthalmology (706)
- Orthopedics (279)
- Otolaryngology (338)
- Pain Medicine (321)
- Palliative Medicine (89)
- Pathology (533)
- Pediatrics (1283)
- Primary Care Research (551)
- Public and Global Health (7391)
- Radiology and Imaging (1676)
- Respiratory Medicine (974)
- Rheumatology (474)
- Sports Medicine (417)
- Surgery (535)
- Toxicology (69)
- Transplantation (233)
- Urology (202)